Eidos Therapeutics Inc (OQ:EIDX)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Dec 13/18 Dec 10/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 2,664 $13.96
Dec 13/18 Dec 10/18 BridgeBio Pharma LLC Direct Ownership Common Stock P - Open market or private purchase 37,989 $13.29
Dec 12/18 Dec 10/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 2,664 $13.96
Dec 12/18 Dec 10/18 BridgeBio Pharma LLC Direct Ownership Common Stock S - Open market or private sale 37,989 $13.29
Feb 14/19 Dec 7/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 4,860 $14.36
Feb 14/19 Dec 7/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 36,314 $13.94
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for EIDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Feb 14/19 Dec 7/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 4,860 $14.36
Feb 14/19 Dec 7/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 36,314 $13.94
Feb 14/19 Dec 6/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 38,970 $13.34
Feb 14/19 Dec 5/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 1,103,848 $14.01
Feb 14/19 Dec 3/18 Satvat Ali J. Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 1,750,000 $15.50
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 2,664 $13.96
Feb 14/19 Dec 10/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 37,989 $13.29
Feb 14/19 Dec 7/18 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 4,860 $14.36
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $EIDX

StockTwits